Last update 15 Nov 2024

Recombinant Human Interferon α2a (Liaoning Satellite Biological)

Overview

Basic Info

Drug Type
Interferons, Biosimilar
Synonyms
干扰素α-2a生物类似药 (辽宁卫星生物)
Target
Mechanism
IFNAR agonists(Interferon alpha/beta receptor agonists), Immunomodulators, Innate antiviral immune response inducers
Inactive Indication-
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Basal Cell Carcinoma
CN
01 Jan 1998
Bladder Cancer
CN
01 Jan 1998
Chronic cervicitis
CN
01 Jan 1998
Chronic leukemia
CN
01 Jan 1998
Condylomata Acuminata
CN
01 Jan 1998
Hairy Cell Leukemia
CN
01 Jan 1998
Hepatitis B, Chronic
CN
01 Jan 1998
Hepatitis C
CN
01 Jan 1998
Hepatitis D
CN
01 Jan 1998
Herpes Zoster
CN
01 Jan 1998
Kaposi Sarcoma
CN
01 Jan 1998
Kidney Neoplasms
CN
01 Jan 1998
Laryngeal Papillomatosis
CN
01 Jan 1998
Melanoma
CN
01 Jan 1998
Multiple Myeloma
CN
01 Jan 1998
Mycosis Fungoides
CN
01 Jan 1998
Pneumonia, Viral
CN
01 Jan 1998
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free